Colorectal Cancer Trial, Recruiting NCT06865638 Sponsor: Nanchong Central Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06865638
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with colorectal cancer (confirmed by a tissue test) and your doctors have planned surgery as part of your treatment.
  • You are between 18 and 85 years old.
  • Your overall health before surgery has been assessed as acceptable for anaesthesia (rated as ASA level I, II, or III by your medical team).
  • You (or your legal representative) are able to understand, sign a consent form, and are willing to take part throughout the whole study.

Who may not be able to join:

  • You have already been diagnosed before surgery with a leaking bowel join or a serious infection in the abdomen.
  • You have serious heart or brain conditions (such as a recent heart attack, unstable chest pain, severe heart failure, or a recent stroke) that mean you cannot safely have surgery or the tests involved.
  • Your liver or kidneys are severely affected — specifically, your liver function is rated at a certain high-risk level, or your kidneys are filtering at a very low rate (confirm with trial site).
  • You have a blood clotting problem that cannot be fixed, or you are on blood-thinning medication that cannot be safely adjusted before the study.
  • You have had radiation treatment to your abdomen before, or have had several abdominal surgeries that caused severe internal scarring, which could interfere with the surgery or tests.
  • You currently have another type of cancer and are actively receiving treatments such as chemotherapy or radiotherapy for it.
  • You have a mental health condition or memory/thinking difficulties that would make it hard to take part in the study or attend follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13508087719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
22 December 2024
Est. completion
31 January 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of Participants with Anastomotic Leak within 30 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov